Neogen (NEOG) Liabilities from Discontinued Operations (2025 - 2026)
Neogen's (NEOG) quarterly Liabilities from Discontinued Operations came in at 6400000.0 in Q1 2026, down 29.72% quarter-over-quarter from 9107000.0 in Q4 2025.
Neogen (NEOG) Liabilities from Discontinued Operations (2025 - 2026) Analysis & Trends
Neogen's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 6400000.0 for Q1 2026.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 6400000.0 in Q1 2026; TTM through Feb 2026 was 6400000.0, a N/A change from a year earlier, with the FY2025 full-year figure at 6600000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations retreated to 6400000.0 in Q1 2026 per NEOG's latest filing, from 9107000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 9107000.0 in Q4 2025 and bottomed at 6400000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn |
| 10 | Neogen | 2.05 Bn | 1.89 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 6.40 Mn |
| Feb 28, 2026 | 6.40 Mn |
| Nov 30, 2025 | 9.11 Mn |
| Nov 30, 2025 | 9.11 Mn |
| May 31, 2025 | 6.60 Mn |
| May 31, 2025 | 6.60 Mn |